Is Pulmicort (budesonide) 90 microgram/actuation safe for a 9-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Pulmicort 90 microgram/actuation for a 9-year-old

Yes, Pulmicort (budesonide) 90 microgram/actuation is safe for a 9-year-old child with asthma. According to the National Asthma Education and Prevention Program guidelines, budesonide is approved and considered safe for children in the 5-11 year age group 1.

Dosing and Safety Information

  • Budesonide is an inhaled corticosteroid (ICS) that has been extensively studied and approved for use in children 5-11 years of age 1
  • For children aged 5-11 years, the recommended low daily dose range of budesonide DPI (dry powder inhaler) is 180-400 mcg, making the 90 mcg/actuation an appropriate strength when used as prescribed 1
  • Budesonide has a high ratio of topical (local) to systemic activity compared to other corticosteroids, which contributes to its favorable safety profile 2
  • The medication undergoes extensive first-pass metabolism to metabolites with minimal activity, which accounts for its low level of systemic effects 2

Efficacy in Children

  • Clinical trials have demonstrated that budesonide is effective in controlling asthma symptoms in children with persistent asthma 3, 4
  • Once-daily or twice-daily administration of budesonide effectively controls asthma in children with mild-to-moderate persistent asthma 5
  • Budesonide has been shown to improve nighttime and daytime asthma symptom scores and reduce the need for breakthrough medication in children 6

Safety Considerations

  • At usual dosages recommended for children, budesonide has little to no effect on adrenal function 2
  • Long-term studies (52 weeks) have shown that budesonide is well tolerated in children with persistent asthma 4
  • The most common adverse effects reported with inhaled budesonide are mild and include:
    • Oral candidiasis (thrush)
    • Dysphonia (voice changes)
    • Sore throat 2
  • Unlike systemic corticosteroids, inhaled budesonide at recommended doses does not typically cause significant systemic side effects such as growth suppression, bone mineral density changes, or cataract formation 5

Important Considerations for Use

  • Proper inhaler technique is essential for effective medication delivery and minimizing side effects 1
  • For children using dry powder inhalers, they must be able to generate sufficient inspiratory flow for adequate lung delivery 1
  • Most 9-year-old children can effectively use dry powder inhalers, but technique should be regularly assessed 1
  • To minimize the risk of oral candidiasis, children should rinse their mouth with water after using the inhaler 1

Conclusion

Pulmicort (budesonide) 90 microgram/actuation is safe and appropriate for a 9-year-old child with asthma when used as prescribed. The medication has been extensively studied in this age group and has a well-established safety profile with minimal systemic effects when used at recommended doses 1, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The role of budesonide in adults and children with mild-to-moderate persistent asthma.

The Journal of asthma : official journal of the Association for the Care of Asthma, 2004

Research

Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.